Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 1.8300
- -0.0200-1.08%
Close Dec 23 16:00 ET
- 1.8594
- +0.0294+1.61%
Post 16:44 ET
375.05MMarket Cap2.90P/E (TTM)
1.8800High1.7800Low1.54MVolume1.8300Open1.8500Pre Close2.81MTurnover1.22%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High4.23P/B230.75MFloat Cap1.190052wk Low--Dividend TTM126.09MShs Float33.3500Historical High--Div YieldTTM5.41%Amplitude0.5000Historical Low1.8230Avg Price1Lot Size
Taysha Gene Therapies Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -20.42%-21.62M | -14.58%-21.5M | 1.92%-19.8M | 17.39%-73.02M | -209.55%-16.12M | 37.70%-17.95M | 43.73%-18.77M | 50.69%-20.19M | 24.48%-88.39M | 136.54%14.71M |
| Net income from continuing operations | 78.20%-25.52M | 14.92%-20.93M | -36.54%-24.06M | 32.80%-111.57M | 186.68%47.74M | -341.39%-117.09M | 27.85%-24.6M | 64.98%-17.62M | 4.88%-166.01M | -9.31%-55.08M |
| Operating gains losses | ---75K | ---195K | --337K | --36.95M | ---63.51M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -11.18%294K | -6.12%322K | -1.81%325K | 16.98%1.37M | 1.10%366K | 19.49%331K | 25.64%343K | 27.31%331K | 138.21%1.17M | 73.21%362K |
| Other non cash items | -55.09%1.38M | -93.92%247K | -75.47%105K | 167.01%9.27M | 198.26%1.71M | 399.35%3.07M | 666.42%4.06M | -75.58%428K | -65.76%3.47M | -80.46%574K |
| Change In working capital | 20.20%-5.88M | -437.94%-4.28M | 105.96%298K | -197.27%-18.01M | -117.11%-4.85M | 3.57%-7.37M | 81.07%-796K | -345.43%-5M | -35.40%18.52M | 1,298.37%28.33M |
| -Change in prepaid assets | -121.18%-741K | -9.57%822K | -73.25%-693K | 187.88%6.01M | 1,754.63%2M | 84.16%3.5M | 575.92%909K | -247.60%-400K | 162.12%2.09M | 105.90%108K |
| -Change in payables and accrued expense | 45.25%-3.35M | -678.55%-3.99M | 3,938.53%4.4M | 49.95%-8.57M | 39.13%-3.25M | 35.83%-6.12M | 117.19%690K | -93.82%109K | -153.48%-17.13M | -238.29%-5.33M |
| -Change in other working capital | 62.33%-1.79M | 53.57%-1.11M | 27.52%-3.41M | -146.04%-15.45M | ---3.6M | ---4.75M | ---2.4M | ---4.71M | --33.56M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -20.42%-21.62M | -14.58%-21.5M | 1.92%-19.8M | 17.39%-73.02M | -209.55%-16.12M | 37.70%-17.95M | 43.73%-18.77M | 50.69%-20.19M | 24.48%-88.39M | 136.54%14.71M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.00%-35K | -518.75%-201K | 96.41%-140K | 70.51%-7.35M | 99.58%-10K | -15.56%-3.49M | 100.59%48K | 65.87%-3.9M | -15.66%-24.93M | 72.18%-2.37M |
| Net PPE purchase and sale | ---35K | -518.75%-201K | 96.41%-140K | 81.24%-3.87M | 99.26%-17K | --0 | 100.61%48K | 53.72%-3.9M | -34.73%-20.62M | 72.08%-2.31M |
| Net intangibles purchase and sale | ---- | ---- | ---- | 17.65%-3.5M | --0 | ---- | ---- | ---- | 32.00%-4.25M | --0 |
| Net other investing changes | ---- | ---- | ---- | 127.87%17K | --7K | ---- | ---- | ---- | ---61K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.00%-35K | -518.75%-201K | 96.41%-140K | 70.51%-7.35M | 99.58%-10K | -15.56%-3.49M | 100.59%48K | 65.87%-3.9M | -15.66%-24.93M | 72.18%-2.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -95.31%6.6M | 18,591.78%70.47M | 94.05%-22K | 161.81%136.39M | -110.30%-4.25M | 136,637.86%140.63M | -96.60%377K | -245.79%-370K | 33.30%52.1M | 352.85%41.23M |
| Net issuance payments of debt | ---- | ---- | ---- | ---3.45M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | -95.27%6.66M | ---- | ---- | 164.42%140.79M | -101.02%-423K | --140.71M | ---- | ---- | --53.24M | --41.6M |
| Proceeds from stock option exercised by employees | 250.00%63K | --0 | -48.00%26K | -73.12%68K | --0 | 126.47%18K | --0 | -81.95%50K | --253K | --0 |
| Net other financing activities | -30.93%-127K | 89.43%-13K | 88.57%-48K | 27.50%-1.02M | -0.81%-375K | -177.14%-97K | 79.80%-123K | -9.38%-420K | -60.18%-1.4M | ---372K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -95.31%6.6M | 18,591.78%70.47M | 94.05%-22K | 161.81%136.39M | -110.30%-4.25M | 136,637.86%140.63M | -96.60%377K | -245.79%-370K | 33.30%52.1M | 352.85%41.23M |
| Net cash flow | ||||||||||
| Beginning cash position | 267.44%175.34M | 91.61%126.58M | 61.89%146.54M | -40.35%90.52M | 351.82%166.92M | -30.72%47.72M | -33.45%66.06M | -40.35%90.52M | -39.61%151.74M | -80.70%36.94M |
| Current changes in cash | -112.63%-15.06M | 365.85%48.76M | 18.38%-19.96M | 191.51%56.02M | -138.03%-20.38M | 473.27%119.2M | 39.65%-18.34M | 53.40%-24.46M | 38.48%-61.22M | 235.04%53.57M |
| End cash Position | -3.97%160.29M | 267.44%175.34M | 91.61%126.58M | 61.89%146.54M | 61.89%146.54M | 351.82%166.92M | -30.72%47.72M | -33.45%66.06M | -40.35%90.52M | -40.35%90.52M |
| Free cash flow | -0.94%-21.65M | -15.95%-21.71M | 17.22%-19.94M | 29.02%-80.39M | -230.08%-16.13M | 32.61%-21.45M | 54.86%-18.72M | 54.01%-24.09M | 18.28%-113.26M | 125.43%12.4M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.